Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

The decreased survival of von Willebrand factor (VWF) in plasma has been implicated as a mechanism in a subset of type 1 von Willebrand disease (VWD) patients. We have previously reported that the ratio of plasma levels of VWF and its propeptide (VWFpp) can be used to identify patients with reduced...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Haberichter, Sandra L., Castaman, Giancarlo, Budde, Ulrich, Peake, Ian, Goodeve, Anne, Rodeghiero, Francesco, Federici, Augusto B., Batlle, Javier, Meyer, Dominique, Mazurier, Claudine, Goudemand, Jenny, Eikenboom, Jeroen, Schneppenheim, Reinhard, Ingerslev, Jorgen, Vorlova, Zdena, Habart, David, Holmberg, Lars, Lethagen, Stefan, Pasi, John, Hill, Frank G. H., Montgomery, Robert R.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2008
Materias:
Hemostasis, Thrombosis, and Vascular Biology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2384129/
https://ncbi.nlm.nih.gov/pubmed/18344424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-09-110940
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares